Reimagining the TGF-β Landscape: Moving Forward to Therapeutic Success
Time: 11:30 am
day: Day One
Details:
- Reviewing links between TGFβ, genomic instability, and cancer
- Using TGFβ’s role in the DNA damage response (DDR) to understand patient response to cancer therapy
- Exploring the predictive value of a TGFβ/DDR signature to position TGFβ inhibitors in cancer therapy